Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion
Condition(s):Prostate Cancer PatientsLast Updated:December 11, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):Prostate Cancer PatientsLast Updated:December 11, 2020Recruiting
Condition(s):Pharmacokinetics of Repaglinide; Pharmacokinetics of Caffeine; Healthy SubjectsLast Updated:May 1, 2014Completed
Condition(s):Type 2 DiabetesLast Updated:August 25, 2009Unknown status
Condition(s):Drug-Drug Interaction (DDI); Healthy SubjectsLast Updated:February 22, 2013Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:May 15, 2013Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:January 20, 2014Completed
Condition(s):Recurrent Ovarian CancerLast Updated:January 22, 2021Not yet recruiting
Condition(s):HealthyLast Updated:May 12, 2015Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:February 10, 2017Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:August 11, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.